Primary Recipient

SAIC FREDERICK, INC

Amount

$10,200,000.00

Award Date

2/04/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

CDFA Program Title

Description

Phase I/II Clinical Trials and Pharmacodynamics NCIG??s Division of Cancer Treatment and Diagnosis (DCTD), under the umbrella of the American Recovery and Reinvestment Act of 2009 (ARRA), is requesting support for several new and expanded initiatives. The

Recipients Connected to Award

Recipient	Role	Amount
SAIC FREDERICK, INC	Primary recipient	$4,921,469.00
APOCELL, INC.	Sub-recipient	$2,927,037.00
MYRIAD RBM, INC.	Sub-recipient	$944,185.00
UCHICAGO ARGONNE, LLC	Sub-recipient	$709,290.00
APOCELL, INC.	Sub-recipient	$148,500.00
EPITOMICS INC.	Sub-recipient	$61,153.00
EPITOMICS INC.	Sub-recipient	$46,907.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$38,917.00
EPITOMICS INC.	Sub-recipient	$35,704.00
EPITOMICS INC.	Sub-recipient	$33,328.00
EPITOMICS INC.	Sub-recipient	$31,565.00
EPITOMICS INC.	Sub-recipient	$27,932.00
EPITOMICS INC.	Sub-recipient	$26,498.00
EPITOMICS INC.	Sub-recipient	$26,465.00
EPITOMICS INC.	Sub-recipient	$26,465.00